{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:44:58Z","timestamp":1784126698957,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96299-7","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T09:38:52Z","timestamp":1744450732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and chronic kidney disease in elderly insights from NHANES"],"prefix":"10.1038","volume":"15","author":[{"given":"Yifan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"key":"96299_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/s0140-6736(13)60687-x","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha, V. et al. Chronic kidney disease: global dimension and perspectives. Lancet 382, 260\u2013272. https:\/\/doi.org\/10.1016\/s0140-6736(13)60687-x (2013).","journal-title":"Lancet"},{"key":"96299_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12325-021-01927-z","volume":"39","author":"M Evans","year":"2022","unstructured":"Evans, M. et al. A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives. Adv. Ther. 39, 33\u201343. https:\/\/doi.org\/10.1007\/s12325-021-01927-z (2022).","journal-title":"Adv. Ther."},{"key":"96299_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12882-021-02590-w","volume":"22","author":"AL Kurniawan","year":"2021","unstructured":"Kurniawan, A. L. et al. Association between metabolic parameters and risks of anemia and electrolyte disturbances among stages 3\u20135 chronic kidney disease patients in Taiwan. BMC Nephrol. 22, 385. https:\/\/doi.org\/10.1186\/s12882-021-02590-w (2021).","journal-title":"BMC Nephrol."},{"key":"96299_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.ki.5002343","volume":"72","author":"AS Levey","year":"2007","unstructured":"Levey, A. S. et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from kidney disease improving global outcomes. Kidney Int. 72, 247\u2013259. https:\/\/doi.org\/10.1038\/sj.ki.5002343 (2007).","journal-title":"Kidney Int."},{"key":"96299_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0140-6736(20)30045-3","volume":"395","author":"Global","year":"2020","unstructured":"Global & national burden of chronic kidney disease. 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 395, 709\u2013733. https:\/\/doi.org\/10.1016\/s0140-6736(20)30045-3 (2020).","journal-title":"Lancet"},{"key":"96299_CR6","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1681\/asn.2005060638","volume":"17","author":"E Ejerblad","year":"2006","unstructured":"Ejerblad, E. et al. Obesity and risk for chronic renal failure. J. Am. Soc. Nephrol. 17, 1695\u20131702. https:\/\/doi.org\/10.1681\/asn.2005060638 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"96299_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41581-021-00454-y","volume":"17","author":"E Brennan","year":"2021","unstructured":"Brennan, E., Kantharidis, P., Cooper, M. E. & Godson, C. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function. Nat. Rev. Nephrol. 17, 725\u2013739. https:\/\/doi.org\/10.1038\/s41581-021-00454-y (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"96299_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova, A., Merscher, S. & Fornoni, A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat. Rev. Nephrol. 19, 629\u2013645. https:\/\/doi.org\/10.1038\/s41581-023-00741-w (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"96299_CR9","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1016\/j.ijcard.2013.03.027","volume":"168","author":"SW Kim","year":"2013","unstructured":"Kim, S. W. et al. Non-HDL-cholesterol\/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B\/apolipoprotein A1. Int. J. Cardiol. 168, 2678\u20132683. https:\/\/doi.org\/10.1016\/j.ijcard.2013.03.027 (2013).","journal-title":"Int. J. Cardiol."},{"key":"96299_CR10","doi-asserted-by":"publisher","first-page":"1501494","DOI":"10.3389\/fnut.2024.1501494","volume":"11","author":"YQ Fan","year":"2024","unstructured":"Fan, Y. Q. et al. The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a predictive indicator of CKD risk in NAFLD patients: NHANES 2017\u20132020. Front. Nutr. 11, 1501494. https:\/\/doi.org\/10.3389\/fnut.2024.1501494 (2024).","journal-title":"Front. Nutr."},{"key":"96299_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12944-024-02152-7","volume":"23","author":"J Wang","year":"2024","unstructured":"Wang, J., Li, S., Pu, H. & He, J. The association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and the risk of osteoporosis among U.S. Adults: analysis of NHANES data. Lipids Health Dis. 23, 161. https:\/\/doi.org\/10.1186\/s12944-024-02152-7 (2024).","journal-title":"Lipids Health Dis."},{"key":"96299_CR12","doi-asserted-by":"publisher","first-page":"1398793","DOI":"10.3389\/fphys.2024.1398793","volume":"15","author":"J Wu","year":"2024","unstructured":"Wu, J. & Guo, J. Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and hypertension in American adults: a NHANES cross-sectional study. Front. Physiol. 15, 1398793. https:\/\/doi.org\/10.3389\/fphys.2024.1398793 (2024).","journal-title":"Front. Physiol."},{"key":"96299_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12944-024-02143-8","volume":"23","author":"MY Tan","year":"2024","unstructured":"Tan, M. Y. et al. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with type 2 diabetes mellitus: recent findings from NHANES 2007\u20132018. Lipids Health Dis. 23, 151. https:\/\/doi.org\/10.1186\/s12944-024-02143-8 (2024).","journal-title":"Lipids Health Dis."},{"key":"96299_CR14","doi-asserted-by":"publisher","first-page":"2427178","DOI":"10.1080\/0886022x.2024.2427178","volume":"46","author":"JD Lu","year":"2024","unstructured":"Lu, J. D. et al. Association between serum neurofilament light chain levels and chronic kidney disease: a cross-sectional population-based study from the National health and nutrition examination survey (2013\u20132014 cycle). Ren. Fail. 46, 2427178. https:\/\/doi.org\/10.1080\/0886022x.2024.2427178 (2024).","journal-title":"Ren. Fail."},{"key":"96299_CR15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.5551\/jat.63118","volume":"29","author":"H Hu","year":"2022","unstructured":"Hu, H. et al. Non-High-Density lipoprotein cholesterol and risk of cardiovascular disease: the Japan epidemiology collaboration on occupational health study. J. Atheroscler Thromb. 29, 1295\u20131306. https:\/\/doi.org\/10.5551\/jat.63118 (2022).","journal-title":"J. Atheroscler Thromb."},{"key":"96299_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12944-024-02262-2","volume":"23","author":"Q Cheng","year":"2024","unstructured":"Cheng, Q. et al. Association of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and gallstones among US adults aged\u2009\u2264\u200950 years: a cross-sectional study from NHANES 2017\u20132020. Lipids Health Dis. 23, 265. https:\/\/doi.org\/10.1186\/s12944-024-02262-2 (2024).","journal-title":"Lipids Health Dis."},{"key":"96299_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006 (2009).","journal-title":"Ann. Intern. Med."},{"key":"96299_CR18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","year":"2021","unstructured":"KDIGO 2021 Clinical practice guideline for the management of glomerular diseases. Kidney Int. 100, S1\u2013s276, doi:https:\/\/doi.org\/10.1016\/j.kint.2021.05.021 (2021).","journal-title":"Kidney Int."},{"key":"96299_CR19","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill, N. R. et al. Global prevalence of chronic kidney disease - A systematic review and meta-analysis. PLoS One. 11, e0158765. https:\/\/doi.org\/10.1371\/journal.pone.0158765 (2016).","journal-title":"PLoS One"},{"key":"96299_CR20","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3760\/cma.j.cn112138-20221013-00755","volume":"62","author":"[Guidelines for the early evaluation","year":"2023","unstructured":"[Guidelines for the early evaluation. And management of chronic kidney disease in China. Zhonghua Nei Ke Za Zhi. 62, 902\u2013930. https:\/\/doi.org\/10.3760\/cma.j.cn112138-20221013-00755 (2023).","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"96299_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41581-024-00863-9","volume":"20","author":"NC Chesnaye","year":"2024","unstructured":"Chesnaye, N. C., Ortiz, A., Zoccali, C., Stel, V. S. & Jager, K. J. The impact of population ageing on the burden of chronic kidney disease. Nat. Rev. Nephrol. 20, 569\u2013585. https:\/\/doi.org\/10.1038\/s41581-024-00863-9 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"96299_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1681\/asn.2016020154","volume":"28","author":"A Denic","year":"2017","unstructured":"Denic, A. et al. The substantial loss of nephrons in healthy human kidneys with aging. J. Am. Soc. Nephrol. 28, 313\u2013320. https:\/\/doi.org\/10.1681\/asn.2016020154 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"96299_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/mnh.0000000000000780","volume":"31","author":"A Denic","year":"2022","unstructured":"Denic, A., Rule, A. D. & Glassock, R. J. Healthy and unhealthy aging on kidney structure and function: human studies. Curr. Opin. Nephrol. Hypertens. 31, 228\u2013234. https:\/\/doi.org\/10.1097\/mnh.0000000000000780 (2022).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"96299_CR24","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/cjn.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic, R. Z., Rooney, M. T. & Tuttle, K. R. Diabetic kidney disease: challenges, progress, and possibilities. Clin. J. Am. Soc. Nephrol. 12, 2032\u20132045. https:\/\/doi.org\/10.2215\/cjn.11491116 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"96299_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.ajkd.2018.12.044","volume":"74","author":"E Ku","year":"2019","unstructured":"Ku, E., Lee, B. J., Wei, J. & Weir, M. R. Hypertension in CKD: core curriculum 2019. Am. J. Kidney Dis. 74, 120\u2013131. https:\/\/doi.org\/10.1053\/j.ajkd.2018.12.044 (2019).","journal-title":"Am. J. Kidney Dis."},{"key":"96299_CR26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/eurheartj\/ehad039","volume":"44","author":"C Zoccali","year":"2023","unstructured":"Zoccali, C. & Mallamaci, F. The cardiovascular-renal link and the health burden of kidney failure. Eur. Heart J. 44, 1167\u20131169. https:\/\/doi.org\/10.1093\/eurheartj\/ehad039 (2023).","journal-title":"Eur. Heart J."},{"key":"96299_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/joim.12081","volume":"274","author":"A Baragetti","year":"2013","unstructured":"Baragetti, A. et al. High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease. J. Intern. Med. 274, 252\u2013262. https:\/\/doi.org\/10.1111\/joim.12081 (2013).","journal-title":"J. Intern. Med."},{"key":"96299_CR28","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1159\/000485861","volume":"42","author":"J Wen","year":"2017","unstructured":"Wen, J. et al. Association of the TG\/HDL-C and Non-HDL-C\/HDL-C ratios with chronic kidney disease in an adult Chinese population. Kidney Blood Press. Res. 42, 1141\u20131154. https:\/\/doi.org\/10.1159\/000485861 (2017).","journal-title":"Kidney Blood Press. Res."},{"key":"96299_CR29","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3967\/bes2024.113","volume":"37","author":"K Lyu","year":"2024","unstructured":"Lyu, K. et al. The effect of blood lipid profiles on chronic kidney disease in a prospective cohort: based on a regression discontinuity design. Biomed. Environ. Sci. 37, 1158\u20131172. https:\/\/doi.org\/10.3967\/bes2024.113 (2024).","journal-title":"Biomed. Environ. Sci."},{"key":"96299_CR30","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.numecd.2015.03.003","volume":"25","author":"PY Zuo","year":"2015","unstructured":"Zuo, P. Y. et al. Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease. Nutr. Metab. Cardiovasc. Dis. 25, 582\u2013587. https:\/\/doi.org\/10.1016\/j.numecd.2015.03.003 (2015).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"96299_CR31","doi-asserted-by":"publisher","unstructured":"Suh, S. H. et al. Non-High-Density lipoprotein cholesterol and progression of chronic kidney disease: results from the KNOW-CKD study. Nutrients 14 https:\/\/doi.org\/10.3390\/nu14214704 (2022).","DOI":"10.3390\/nu14214704"},{"key":"96299_CR32","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41581-021-00423-5","volume":"17","author":"H Noels","year":"2021","unstructured":"Noels, H., Lehrke, M., Vanholder, R. & Jankowski, J. Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations. Nat. Rev. Nephrol. 17, 528\u2013542. https:\/\/doi.org\/10.1038\/s41581-021-00423-5 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"96299_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2014.02.006","volume":"234","author":"JA Lamprea-Montealegre","year":"2014","unstructured":"Lamprea-Montealegre, J. A. et al. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study. Atherosclerosis 234, 42\u201346. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.02.006 (2014).","journal-title":"Atherosclerosis"},{"key":"96299_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","volume":"159","author":"J Soppert","year":"2020","unstructured":"Soppert, J., Lehrke, M., Marx, N., Jankowski, J. & Noels, H. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv. Drug Deliv Rev. 159, 4\u201333. https:\/\/doi.org\/10.1016\/j.addr.2020.07.019 (2020).","journal-title":"Adv. Drug Deliv Rev."},{"key":"96299_CR35","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1161\/01.ATV.0000142804.27420.5b","volume":"24","author":"HB Brewer Jr","year":"2004","unstructured":"Brewer, H. B. Jr., Remaley, A. T., Neufeld, E. B., Basso, F. & Joyce, C. Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease. Arterioscler. Thromb. Vasc Biol. 24, 1755\u20131760. https:\/\/doi.org\/10.1161\/01.ATV.0000142804.27420.5b (2004).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"96299_CR36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1053\/j.ajkd.2018.11.010","volume":"73","author":"A Bajaj","year":"2019","unstructured":"Bajaj, A. et al. Lipids, apolipoproteins, and risk of atherosclerotic cardiovascular disease in persons with CKD. Am. J. Kidney Dis. 73, 827\u2013836. https:\/\/doi.org\/10.1053\/j.ajkd.2018.11.010 (2019).","journal-title":"Am. J. Kidney Dis."},{"key":"96299_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/1753-0407.13232","volume":"14","author":"C Mende","year":"2022","unstructured":"Mende, C. & Einhorn, D. Fatty kidney disease: the importance of ectopic fat deposition and the potential value of imaging. J. Diabetes. 14, 73\u201378. https:\/\/doi.org\/10.1111\/1753-0407.13232 (2022).","journal-title":"J. Diabetes"},{"key":"96299_CR38","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.1152\/ajpendo.00179.2022","volume":"324","author":"Z Jiang","year":"2023","unstructured":"Jiang, Z. et al. Obesity and chronic kidney disease. Am. J. Physiol. Endocrinol. Metab. 324, E24\u2013e41. https:\/\/doi.org\/10.1152\/ajpendo.00179.2022 (2023).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"96299_CR39","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ebiom.2016.10.020","volume":"13","author":"G Krievina","year":"2016","unstructured":"Krievina, G. et al. Ectopic adipose tissue storage in the left and the right renal sinus is asymmetric and associated with serum kidney injury Molecule-1 and fibroblast growth Factor-21 levels increase. EBioMedicine 13, 274\u2013283. https:\/\/doi.org\/10.1016\/j.ebiom.2016.10.020 (2016).","journal-title":"EBioMedicine"},{"key":"96299_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","volume":"144","author":"CY Hsu","year":"2006","unstructured":"Hsu, C. Y., McCulloch, C. E., Iribarren, C., Darbinian, J. & Go, A. S. Body mass index and risk for end-stage renal disease. Ann. Intern. Med. 144, 21\u201328. https:\/\/doi.org\/10.7326\/0003-4819-144-1-200601030-00006 (2006).","journal-title":"Ann. Intern. Med."},{"key":"96299_CR41","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/j.1523-1755.2004.00582.x","volume":"65","author":"K Iseki","year":"2004","unstructured":"Iseki, K. et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 65, 1870\u20131876. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00582.x (2004).","journal-title":"Kidney Int."},{"key":"96299_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1053\/j.jrn.2006.04.017","volume":"16","author":"P Rutkowski","year":"2006","unstructured":"Rutkowski, P., Klassen, A., Sebekova, K., Bahner, U. & Heidland, A. Renal disease in obesity: the need for greater attention. J. Ren. Nutr. 16, 216\u2013223. https:\/\/doi.org\/10.1053\/j.jrn.2006.04.017 (2006).","journal-title":"J. Ren. Nutr."},{"key":"96299_CR43","doi-asserted-by":"publisher","first-page":"1095211","DOI":"10.3389\/fendo.2022.1095211","volume":"13","author":"T Arabi","year":"2022","unstructured":"Arabi, T. et al. Obesity-related kidney disease: beyond hypertension and insulin-resistance. Front. Endocrinol. (Lausanne). 13, 1095211. https:\/\/doi.org\/10.3389\/fendo.2022.1095211 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"96299_CR44","doi-asserted-by":"publisher","unstructured":"Nakashima, A., Kato, K., Ohkido, I. & Yokoo, T. Role and treatment of insulin resistance in patients with chronic kidney disease: A review. Nutrients 13 https:\/\/doi.org\/10.3390\/nu13124349 (2021).","DOI":"10.3390\/nu13124349"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96299-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96299-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96299-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T09:38:55Z","timestamp":1744450735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96299-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96299"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96299-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The NHANES protocols received approval from the National Center for Health Statistics Ethics Review Board of the U.S. CDC, and all participants provided written informed consent during the survey.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"12611"}}